Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM027757-005
Application #
2300508
Study Section
Project Start
1992-06-30
Project End
1997-06-29
Budget Start
1995-11-21
Budget End
1996-06-29
Support Year
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Arizona
Department
Other Health Professions
Type
Schools of Pharmacy
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Pinsuwan, S; Alvarez-Nunez, F A; Tabibi, E S et al. (1999) Degradation kinetics of 4-dedimethylamino sancycline, a new anti-tumor agent, in aqueous solutions. Int J Pharm 181:31-40
Li, P; Tabibi, S E; Yalkowsky, S H (1999) Solubilization of ionized and un-ionized flavopiridol by ethanol and polysorbate 20. J Pharm Sci 88:507-9
Li, P; Tabibi, S E; Yalkowsky, S H (1999) Solubilization of flavopiridol by pH control combined with cosolvents, surfactants, or complexants. J Pharm Sci 88:945-7
Li, P; Tabibi, S E; Yalkowsky, S H (1998) Combined effect of complexation and pH on solubilization. J Pharm Sci 87:1535-7
Simamora, P; Dannenfelser, R M; Tabibi, S E et al. (1998) Emulsion formulations for intravenous administration of paclitaxel. PDA J Pharm Sci Technol 52:170-2
Krzyzaniak, J F; Alvarez Nunez, F A; Raymond, D M et al. (1997) Lysis of human red blood cells. 4. Comparison of in vitro and in vivo hemolysis data. J Pharm Sci 86:1215-7
Alvarez Nunez, F A; Yalkowsky, S H (1997) Correlation between log P and ClogP for some steroids. J Pharm Sci 86:1187-9
Heimbecher, S; Lee, Y C; Tabibi, S E et al. (1997) Derivatization and high-performance liquid chromatographic analysis of pentaazapentacosane pentahydrochloride. J Chromatogr B Biomed Sci Appl 691:173-8
Dannenfelser, R M; Surakitbanharn, Y; Tabibi, S E et al. (1996) Parenteral formulation of Flavopiridol (NSC-649890). PDA J Pharm Sci Technol 50:356-9
Krzyzaniak, J F; Raymond, D M; Yalkowsky, S H (1996) Lysis of human red blood cells 1: Effect of contact time on water induced hemolysis. PDA J Pharm Sci Technol 50:223-6